NeoGenomics Inc., a specialty oncology testing laboratory, has officially opened the doors of its first specialized oncology laboratory outside the United States in Rolle, Switzerland. The location was chosen as the company’s European Headquarters because of the existing talent pool, favorable business environment, and proximity to leading academic institutions in the area.
The opening ceremony on November 8th included an official ribbon-cutting, a brief presentation of NeoGenomics’ oncology testing services, and personalized tours of the facility. The open house kicks off their plans to provide esoteric testing for the global oncology research community.
“NeoGenomics is absolutely delighted to open our first specialized oncology laboratory outside the United States here in Rolle,” said Douglas VanOort, NeoGenomics’ chairman and chief executive officer. “We are very appreciative of the opportunity to join this vibrant community."